The global market for ambulatory blood pressure monitoring is examined in a recent market research report by Transparency Market Research, titled “Ambulatory Blood Pressure Monitoring Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020.” The report gives a thorough overview of the chief drivers, challenges, regulatory factors, and prominent changes of the past and present times that are expected to reflect significantly on the way the market’s development will take course in the near future.
Download PDF brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3696
The chief factor driving the ambulatory blood pressure market is the rising number of people suffering from blood pressure issues globally. The World Hearth Federation (WHF) states that as of 2012, an estimated one billion people globally suffered from high blood pressure or hypertension, a number which is expected to rise to over 1.5 billion by 2025. In this scenario, the need for effective and quick blood pressure measurement and monitoring solutions will significantly intensify in the next few years, generating vast growth opportunities for the global ambulatory blood pressure monitoring market.
The global ambulatory blood pressure monitoring market is also driven by the strategy of product bundling, referring to the act of offering a complete set of essential healthcare devices/ solutions such as blood glucose monitor, pulse oximeter, and thermometer along with ambulatory blood pressure monitoring as a combined product. A variety of such economical and thoughtful combinations are witnessing increased demand on the consumer end and a rising number of vendors are adopting the strategy for sustainable returns.
Owing to the presence of several small-scale vendors, especially in developing economies, price competition has become intense in the global ambulatory blood pressure monitoring market. With an increasing number of companies expected to introduce blood pressure monitors at cheaper rates in the near future, cost-wars are expected to further intensify.
From a geographical perspective, North America and Europe are presently the dominant regional markets for ambulatory blood pressure monitoring. The factors aiding the growth of the market across these regions include the rising aging population, initiatives undertaken by government and private bodies to raise awareness regarding symptoms and health effects of hypertension, and high disposable incomes of the population.
Over the next few years, the Asia Pacific ambulatory blood pressure monitoring market is expected to exhibit expansion at a comparatively faster rate. Factors supporting the market’s growth in this region include rising disposable incomes, increased healthcare awareness, and government support and focus towards the improvement of healthcare facilities.
Some of the most notable vendors operating in the global ambulatory blood pressure monitoring market are Welch Allyn, Inc., A&D Company, Microlife AG, Omron Healthcare Company, Ltd., GE Healthcare, Schiller AG, AViTA Corporation, and SunTech Medical.